| Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy JA Woyach, K Smucker, LL Smith, A Lozanski, Y Zhong, AS Ruppert, ... Blood, The Journal of the American Society of Hematology 123 (12), 1810-1817, 2014 | 341 | 2014 |
| MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia B Cui, L Chen, S Zhang, M Mraz, JF Fecteau, J Yu, EM Ghia, L Zhang, ... Blood, The Journal of the American Society of Hematology 124 (4), 546-554, 2014 | 242 | 2014 |
| Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers C DeBoever, EM Ghia, PJ Shepard, L Rassenti, CL Barrett, K Jepsen, ... PLoS computational biology 11 (3), e1004105, 2015 | 226 | 2015 |
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia B Falini, MP Martelli, N Bolli, R Bonasso, E Ghia, MT Pallotta, D Diverio, ... Blood 108 (6), 1999-2005, 2006 | 219 | 2006 |
| Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia L Wang, AN Brooks, J Fan, Y Wan, R Gambe, S Li, S Hergert, S Yin, ... Cancer cell 30 (5), 750-763, 2016 | 210 | 2016 |
| Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy S Zhang, B Cui, H Lai, G Liu, EM Ghia, GF Widhopf, Z Zhang, CCN Wu, ... Proceedings of the National Academy of Sciences 111 (48), 17266-17271, 2014 | 193 | 2014 |
| miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1 M Mraz, L Chen, LZ Rassenti, EM Ghia, H Li, K Jepsen, EN Smith, ... Blood, The Journal of the American Society of Hematology 124 (1), 84-95, 2014 | 178 | 2014 |
| Phase I trial: cirmtuzumab inhibits ROR1 signaling and stemness signatures in patients with chronic lymphocytic leukemia MY Choi, GF Widhopf, EM Ghia, RL Kidwell, MK Hasan, J Yu, LZ Rassenti, ... Cell Stem Cell 22 (6), 951-959. e3, 2018 | 146 | 2018 |
| High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia B Cui, EM Ghia, L Chen, LZ Rassenti, C DeBoever, GF Widhopf, J Yu, ... Blood, The Journal of the American Society of Hematology 128 (25), 2931-2940, 2016 | 138 | 2016 |
| Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody S Zhang, H Zhang, EM Ghia, J Huang, L Wu, J Zhang, S Lam, Y Lei, J He, ... Proceedings of the National Academy of Sciences 116 (4), 1370-1377, 2019 | 111 | 2019 |
| The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience DL Van Dyke, L Werner, LZ Rassenti, D Neuberg, E Ghia, NA Heerema, ... British journal of haematology 173 (1), 105-113, 2016 | 111 | 2016 |
| ROR1 can interact with TCL1 and enhance leukemogenesis in Eµ-TCL1 transgenic mice GF Widhopf, B Cui, EM Ghia, L Chen, K Messer, Z Shen, SP Briggs, ... Proceedings of the National Academy of Sciences 111 (2), 793-798, 2014 | 111 | 2014 |
| Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53 JF Fecteau, LG Corral, EM Ghia, S Gaidarova, D Futalan, IS Bharati, ... Blood, The Journal of the American Society of Hematology 124 (10), 1637-1644, 2014 | 105 | 2014 |
| Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B MK Kashyap, D Kumar, R Villa, JJ La Clair, C Benner, R Sasik, H Jones, ... Haematologica 100 (7), 945, 2015 | 94 | 2015 |
| Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection EM Ghia, S Jain, GF Widhopf, LZ Rassenti, MJ Keating, WG Wierda, ... Blood, The Journal of the American Society of Hematology 111 (10), 5101-5108, 2008 | 94 | 2008 |
| A murine model of chronic lymphocytic leukemia based on B cell-restricted expression of Sf3b1 mutation and Atm deletion S Yin, RG Gambe, J Sun, AZ Martinez, ZJ Cartun, FFD Regis, Y Wan, ... Cancer Cell 35 (2), 283-296. e5, 2019 | 93 | 2019 |
| Comprehensive characterization of IGHV3-21–expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study R Bomben, M Dal Bo, D Capello, D Benedetti, D Marconi, A Zucchetto, ... Blood 109 (7), 2989-2998, 2007 | 87 | 2007 |
| Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen C Steininger, GF Widhopf, EM Ghia, CS Morello, K Vanura, R Sanders, ... Blood, The Journal of the American Society of Hematology 119 (10), 2293-2301, 2012 | 84 | 2012 |
| Dielectrophoretic isolation and detection of cancer‐related circulating cell‐free DNA biomarkers from blood and plasma A Sonnenberg, JY Marciniak, EA Skowronski, S Manouchehri, L Rassenti, ... Electrophoresis 35 (12-13), 1828-1836, 2014 | 77 | 2014 |
| Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood A Sonnenberg, JY Marciniak, L Rassenti, EM Ghia, EA Skowronski, ... Clinical chemistry 60 (3), 500-509, 2014 | 72 | 2014 |
